Galvani Bioelectronics Limited;Johns Hopkins University
发明人:
Arun Sridhar,Liansheng Liu,Pankaj Jay Pasricha
申请号：
GB201708076
公开号：
GB2552249A
申请日:
2017.05.19
申请国别(地区):
GB
年份:
2018
代理人:
摘要：
A method of treatment involving inhibition of signalling by the greater splanchnic nerve may lead to an improvement in oral glucose tolerance. Treatment is applied by means of transducers applying a signal to the greater splanchnic nerve. The device may also monitor physiological parameters, such as blood pressure, insulin, glucose, plasma catecholamine, tissue catecholamine and plasma HbA1c. The device may apply an alternating current waveform between 1 and 50 kHz. The transducers may be electrodes on a bipolar electrode cuff.
